Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.

Authors

G F. Gjerset
M C. Pike
J W. Mosley
J Hassett
Mary A. Fletcher, Nova Southeastern UniversityFollow
E Donegan
J W. Parker
R B. Counts
Y Zhou
C K. Kasper

Publication Title

Blood

ISSN

0006-4971

Publication Date

9-1-1994

Volume

84

Issue

5

First Page

1666

Last Page

1671

Disciplines

Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy

NSUWorks Citation

Gjerset, G F.; Pike, M C.; Mosley, J W.; Hassett, J; Fletcher, Mary A.; Donegan, E; Parker, J W.; Counts, R B.; Zhou, Y; and Kasper, C K., "Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group." (1994). Faculty Articles. 134.
https://nsuworks.nova.edu/hpd_com_faculty_articles/134